ArticleThe AAPS journal2025

Analysis on the Impact of U.S. FDA's Narrow Therapeutic Index Bioequivalence Criteria on Generic Drug Applications.

Krista Anim Anno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.